Aberdeen Group plc

Holdings History for Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE)

Symbol: RARE on Nasdaq
Investment type: Equity / COMMON STOCK

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.05%	+0.02%	$33,808,873	1,469,951	+496,295	+51%	$23.00	Q4 2025
30 Sep 2025	0.05%	+0.02%	$29,287,572	973,656	+472,600	+94%	$30.08	Q3 2025
30 Jun 2025	0.03%	+0%	$18,218,396	501,056	+22,152	+4.6%	$36.36	Q2 2025
31 Mar 2025	0.03%	+0.01%	$17,341,114	478,904	+161,779		$36.21	Q1 2025
31 Dec 2024	0.03%	+0.01%	$13,341,449	317,125	+63,821	+25%	$42.07	Q4 2024
30 Sep 2024	0.03%	-0%	$14,071,037	253,304	-31,441	-11%	$55.55	Q3 2024
30 Jun 2024	0.02%	+0.01%	$11,703,020	284,745	+143,628	+102%	$41.10	Q2 2024
31 Mar 2024	0.01%	0%	$6,588,753	141,117	0		$46.69	Q1 2024
31 Dec 2023	0.01%	+0.01%	$6,748,215	141,117	+141,117	NEW	$47.82	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.